Life Sciences
Healthcare organizations and technology companies must work together to ensure responsible and ethical AI use and to explore the true benefits of AI.
Digital health stakeholders said that AI will be used next year to help ease administrative tasks for providers, improve clinical trial participation and increase transparency in healthcare.
The California-based company will use the funds to expand its Whole Body Twin Technology, aimed at preventing and reversing metabolic disease.
Rock Health's Digital Health at the Turn of 2024 report found retailers as providers and data interoperability are scaling innovations in the sector, with lasting trajectories.
The kit was determined to be comparable to a device used in clinically-administered intrauterine insemination.
Foley & Lardner's Nathaniel Lacktman and Louis Lehot discuss which categories of digital health hold the most potential for M&As and why in this contributed piece.
Execs overwhelmingly cite genAI as having the most significant impact in healthcare this year, though others provide alternative takes on the years' events.
The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.
The partners will initially launch in two clinics in Texas to provide patients with ALS access to virtual-first specialty care providers, including respiratory therapists.
Dr. Michael Howell, chief clinical officer at Google, discusses Med-PaLM's evolution in 2023 and recommendations for regulators developing rules for AI use in healthcare.